Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CareDx (CDNA)
NASDAQ:CDNA
Holding CDNA?
Track your performance easily
CDNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.42 - $34.84
Previous Close$20.61
Volume1.79M
Average Volume (3M)846.43K
Market Cap
$1.10B
Enterprise Value$885.16M
Total Cash (Recent Filing)$240.85M
Total Debt (Recent Filing)$23.84M
Price to Earnings (P/E)―
Beta2.05
Next Earnings
Feb 26, 2025EPS Estimate
-$0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.70
Shares Outstanding53,633,871
10 Day Avg. Volume651,649
30 Day Avg. Volume846,429
Standard Deviation0.23
R-Squared0.17
Alpha0.00504
Financial Highlights & Ratios
Price to Book (P/B)4.05
Price to Sales (P/S)3.52
Price to Cash Flow (P/CF)22.00
P/FCF Ratio25.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.83
Enterprise Value/Gross Profit4.96
Enterprise Value/Ebitda-29.44
Forecast
1Y Price Target
$34.50Price Target Upside67.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
CareDx News
PremiumCompany Announcements
CareDx Inc. Reports Solid Growth and Raises Guidance
PremiumPre-Earnings
Is CDNA a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Financial PerformanceCDNA delivered $83M of revenue in Q3, matching its pre-announce and beating the Street by $3M.
Growth StrategyCareDx is targeting 15% CAGR growth to reach $500M in revenue in 2027.
Regulatory And LegalThe Department of Justice concluded its investigation into CareDx with no finding of wrongdoing and declined to take any further action.
Bears Say
Growth ExpectationsInvestors may question just how much growth CDNA can realistically capture from the 'portfolio halo effect' argument.
Management GuidanceManagement did not update its '24 guidance, which is viewed as negative.
Revenue And Volume PerformanceShares were down 16% due to factors such as lower-than-expected Q3 revenue beat and volume growth, lack of full-year guidance reiteration, limited discussion on surveillance testing, and no Q&A during the Investor Day webcast.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CDNA FAQ
What was CareDx’s price range in the past 12 months?
CareDx lowest stock price was $7.42 and its highest was $34.84 in the past 12 months.
What is CareDx’s market cap?
Currently, no data Available
When is CareDx’s upcoming earnings report date?
CareDx’s upcoming earnings report date is Feb 26, 2025 which is in 67 days.
How were CareDx’s earnings last quarter?
CareDx released its earnings results on Nov 04, 2024. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.246 by $0.106.
Is CareDx overvalued?
According to Wall Street analysts CareDx’s price is currently Undervalued.
Does CareDx pay dividends?
CareDx does not currently pay dividends.
What is CareDx’s EPS estimate?
CareDx’s EPS estimate is -$0.22.
How many shares outstanding does CareDx have?
CareDx has 53,633,870 shares outstanding.
What happened to CareDx’s price movement after its last earnings report?
CareDx reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.246. Following the earnings report the stock price went down -0.131%.
Which hedge fund is a major shareholder of CareDx?
Among the largest hedge funds holding CareDx’s share is ARK Investment Management LLC. It holds CareDx’s shares valued at 93M.
---
CareDx Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$34.50 (67.39% Upside)
$34.50 (67.39% Upside)
Blogger Sentiment
Neutral
CDNA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 2.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.5%
Last 30 Days ▼ 14.0%
Last 30 Days ▼ 14.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
90.48%
12-Months-Change
Fundamentals
Return on Equity
-43.02%
Trailing 12-Months
Asset Growth
-4.83%
Trailing 12-Months
Company Description
CareDx
CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
---
CDNA Company Deck
---
CDNA Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with strong growth metrics and achievements, such as significant revenue growth, positive EBITDA, and resolution of legal matters. However, there were some concerns about the flat revenue growth expected in Q4 and the impact of external factors like Hurricane Milton. Overall, the positive aspects outweighed the negative, showing a strong growth trajectory for CareDx.Read More>---
CDNA Stock 12 Month Forecast
Average Price Target
$34.50
▲(67.39% Upside)
Technical Analysis
Best Analysts Covering CDNA
1 Year
1 Year Success Rate
3/8 ratings generated profit
1 Year Average Return
-18.04%
reiterated a buy rating 2 months ago
Copying Matthew Sykes's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -18.04% per trade.
---